drugset / Trial / NCT02365961

Hip Scope Fascia-iliaca (FI) Block Study

NCT02365961

Phase 4 Completed 84 enrolled The Hawkins Foundation
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

Timeline

Start
2015-04
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Noropin Unknown 0.5 %
Comparator Noropin Unknown 30 ml
Subject Ropivacaine Other / unclassified 0.35 %
Subject Ropivacaine Other / unclassified 3 mg/kg
Subject Ropivacaine Other / unclassified 60 ml
Background Clonidine Other / unclassified 100 ug
Background Epinephrine Other / unclassified